CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents ($49,227 and $79,746 restricted at December 31, 2020 and September 30, 2021, respectively)	$ 1,038,458	$ 1,144,450
Accounts receivable, net	827,169	743,502
Short-term investments ($88,867 and $101,884 restricted at December 31, 2020 and September 30, 2021, respectively)	155,518	140,847
Pharmaceutical inventory	39,832	43,334
Other current assets ($43,547 and $74,385 restricted at December 31, 2020 and September 30, 2021, respectively)	143,442	84,264
Total Current Assets	2,204,419	2,156,397
Property and equipment, net	137,046	136,739
Long-term investments ($1,026 and $0 restricted at December 31, 2020 and September 30, 2021, respectively)		2,612
Deferred income taxes		1,842
Other long-term assets	81,008	108,797
Goodwill	873,830	873,779
Other intangible assets, net	57,147	79,689
Total Assets	3,353,450	3,359,855
Current Liabilities:
Accounts payable	171,774	137,380
Accrued liabilities	231,196	354,906
Medical claims payable	187,177	111,851
Other medical liabilities	162,658	126,921
Current debt, finance lease and deferred financing obligations	3,214	6,521
Total Current Liabilities	756,019	737,579
Long-term debt, finance lease and deferred financing obligations	516,368	631,855
Deferred income taxes	18,768	7,102
Tax contingencies	12,913	11,002
Deferred credits and other long-term liabilities	76,219	69,283
Total Liabilities	1,380,287	1,456,821
Redeemable non-controlling interest	39,261	33,062
Stockholder's Equity:
Preferred stock, par value $.01 per share Authorized-10,000 shares at December 31, 2020 and September 30, 2021-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2020 and September 30, 2021-Issued and outstanding-55,549 and 25,887 shares at December 31, 2020, respectively, and 55,994 and 26,332 shares at September 30, 2021, respectively	560	555
Other Stockholders' Equity:
Additional paid-in capital	1,512,919	1,477,219
Retained earnings	1,885,194	1,857,130
Accumulated other comprehensive loss	(44)	(205)
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2020 and September 30, 2021, respectively	(1,464,727)	(1,464,727)
Total Stockholders' Equity	1,933,902	1,869,972
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity	$ 3,353,450	$ 3,359,855